Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
POINT OF VIEW  

 Article Access Statistics
    Viewed15506    
    Printed341    
    Emailed4    
    PDF Downloaded833    
    Comments [Add]    
    Cited by others 10    

Recommend this journal


Click on image for details.

 Rheumatic fever pathogenesis: Approach in research needs change

Rajendra Tandon
Department of Cardiology, Sitaram Bhartia Institute of Science and Research, B-16, Mehrauli Institutional Area, New Delhi, India

Correspondence Address:
Rajendra Tandon
Sitaram Bhartia Institute of Science and Research, B-16, Mehrauli Institutional Area, New Delhi-110016
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2069.99621

Rights and Permissions

Year : 2012  |  Volume : 5  |  Issue : 2  |  Page : 169-178

 
SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (1,628 KB)
Email article
Print Article
Add to My List
Despite identifying that rheumatic fever (RF) is the result of an immunological reaction following group-A beta-hemolytic streptococcal infection, the pathogenesis remains elusive. RF has been incorrectly designated as causing pancarditis, since it does not cause myocarditis. Research directed toward myocarditis, targeting myosin to unravel the pathogenesis has not succeeded in more than 60 years. RF causes permanent damage to cardiac valves. The mitral valve (MV), derived from the wall of the left ventricle, is composed of a central core of connective tissue, covered on both sides by endothelium. The left ventricle does not have either myocardial or intermyocardial connective tissue involvement in RF. By exclusion, therefore, the primary site of RF damage appears to be the endothelium. Evaluation of the histopathology and immunopathology indicates that RF is a disease of the valvular and vascular endothelium. It is not a connective tissue disorder. Research to identify pathogenesis needs to be focused toward valvular endothelium.






[FULL TEXT] [PDF]*
 

 

 Whats new | Sitemap | Feedback | Copyright and Disclaimer | Privacy Notice

 © 2008 Annals of Pediatric Cardiology | Published by Wolters Kluwer - Medknow
 Online since 20th April, 2008

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 POINT OF VIEW
 



Rajendra Tandon
Department of Cardiology, Sitaram Bhartia Institute of Science and Research, B-16, Mehrauli Institutional Area, New Delhi, India

Correspondence Address:
Rajendra Tandon
Sitaram Bhartia Institute of Science and Research, B-16, Mehrauli Institutional Area, New Delhi-110016
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2069.99621

Rights and Permissions

Despite identifying that rheumatic fever (RF) is the result of an immunological reaction following group-A beta-hemolytic streptococcal infection, the pathogenesis remains elusive. RF has been incorrectly designated as causing pancarditis, since it does not cause myocarditis. Research directed toward myocarditis, targeting myosin to unravel the pathogenesis has not succeeded in more than 60 years. RF causes permanent damage to cardiac valves. The mitral valve (MV), derived from the wall of the left ventricle, is composed of a central core of connective tissue, covered on both sides by endothelium. The left ventricle does not have either myocardial or intermyocardial connective tissue involvement in RF. By exclusion, therefore, the primary site of RF damage appears to be the endothelium. Evaluation of the histopathology and immunopathology indicates that RF is a disease of the valvular and vascular endothelium. It is not a connective tissue disorder. Research to identify pathogenesis needs to be focused toward valvular endothelium.






[FULL TEXT] [PDF]*


        
Print this article     Email this article  

 Whats new | Sitemap | Feedback | Copyright and Disclaimer | Privacy Notice

 © 2008 Annals of Pediatric Cardiology | Published by Wolters Kluwer - Medknow
 Online since 20th April, 2008